Guardion Health Sciences, Inc. (GHSI)

USD 3.22

(0.0%)

Total Debt Summary of Guardion Health Sciences, Inc.

  • Guardion Health Sciences, Inc.'s latest annual total debt in 2023 was - USD , down -100.0% from previous year.
  • Guardion Health Sciences, Inc.'s latest quarterly total debt in 2024 Q1 was - USD , down 0.0% from previous quarter.
  • Guardion Health Sciences, Inc. reported annual total debt of 3807.00 USD in 2022, down -85.37% from previous year.
  • Guardion Health Sciences, Inc. reported annual total debt of 26.02 Thousand USD in 2021, down -94.01% from previous year.
  • Guardion Health Sciences, Inc. reported quarterly total debt of - USD for 2024 Q2, down 0.0% from previous quarter.
  • Guardion Health Sciences, Inc. reported quarterly total debt of - USD for 2023 Q4, down 0.0% from previous quarter.

Annual Total Debt Chart of Guardion Health Sciences, Inc. (2023 - 2013)

Historical Annual Total Debt of Guardion Health Sciences, Inc. (2023 - 2013)

Year Total Debt Total Debt Growth
2023 - USD -100.0%
2022 3807.00 USD -85.37%
2021 26.02 Thousand USD -94.01%
2020 434.74 Thousand USD -25.85%
2019 586.31 Thousand USD 0.0%
2018 - USD -100.0%
2017 30.53 Thousand USD -57.22%
2016 71.37 Thousand USD -90.75%
2015 771.53 Thousand USD -55.34%
2014 1.72 Million USD 63.87%
2013 1.05 Million USD 0.0%

Peer Total Debt Comparison of Guardion Health Sciences, Inc.

Name Total Debt Total Debt Difference
Cumberland Pharmaceuticals Inc. 18.42 Million USD 100.0%
Harrow Health, Inc. 190.5 Million USD 100.0%
Dynavax Technologies Corporation 256.91 Million USD 100.0%
Biofrontera Inc. 5.39 Million USD 100.0%
DURECT Corporation 20.74 Million USD 100.0%
Cronos Group Inc. 2.53 Million USD 100.0%
Ironwood Pharmaceuticals, Inc. 715.53 Million USD 100.0%
Kala Pharmaceuticals, Inc. 36.32 Million USD 100.0%
RedHill Biopharma Ltd. 1.17 Million USD 100.0%
Radius Health, Inc. 365.31 Million USD 100.0%
Universe Pharmaceuticals INC 5.48 Million USD 100.0%
ProPhase Labs, Inc. 21.38 Million USD 100.0%
Phibro Animal Health Corporation 525.45 Million USD 100.0%
China SXT Pharmaceuticals, Inc. 2.64 Million USD 100.0%
Procaps Group S.A. 285.93 Million USD 100.0%
Alvotech 1.07 Billion USD 100.0%
TherapeuticsMD, Inc. 8 Million USD 100.0%
Rockwell Medical, Inc. 13.43 Million USD 100.0%
Sunshine Biopharma, Inc. 657.7 Thousand USD 100.0%
Alpha Teknova, Inc. 30.45 Million USD 100.0%
Intra-Cellular Therapies, Inc. 16.93 Million USD 100.0%
SCYNEXIS, Inc. 15.08 Million USD 100.0%
Aytu BioPharma, Inc. 15.12 Million USD 100.0%
Theratechnologies Inc. 58.96 Million USD 100.0%
ANI Pharmaceuticals, Inc. 315.32 Million USD 100.0%
Sonoma Pharmaceuticals, Inc. 608 Thousand USD 100.0%
Safety Shot Inc 1.54 Million USD 100.0%
Supernus Pharmaceuticals, Inc. 41.52 Million USD 100.0%
SIGA Technologies, Inc. 1.46 Million USD 100.0%
Tilray Brands, Inc. 387.31 Million USD 100.0%
Lifecore Biomedical, Inc. 130.36 Million USD 100.0%
Viatris Inc. 18.12 Billion USD 100.0%
PetIQ, Inc. 468.3 Million USD 100.0%
OptiNose, Inc. 131.74 Million USD 100.0%
Neurocrine Biosciences, Inc. 428.4 Million USD 100.0%
Sunshine Biopharma, Inc. 657.7 Thousand USD 100.0%
Organogenesis Holdings Inc. 119.35 Million USD 100.0%
Alimera Sciences, Inc. 67.39 Million USD 100.0%
Collegium Pharmaceutical, Inc. 674.28 Million USD 100.0%
Silver Spike Investment Corp. - USD NaN%
Assertio Holdings, Inc. 40.91 Million USD 100.0%
Shuttle Pharmaceuticals Holdings, Inc. 1.08 Million USD 100.0%
Cosmos Health Inc. 12.42 Million USD 100.0%
Journey Medical Corporation 17.73 Million USD 100.0%
Petros Pharmaceuticals, Inc. 8.27 Million USD 100.0%
Clever Leaves Holdings Inc. 2.08 Million USD 100.0%
Embecta Corp. 1.63 Billion USD 100.0%
Regencell Bioscience Holdings Limited 59.8 Thousand USD 100.0%
Procaps Group, S.A. 285.93 Million USD 100.0%
PainReform Ltd. 86 Thousand USD 100.0%
Incannex Healthcare Limited 373 Thousand USD 100.0%
Cyclo Therapeutics, Inc. 1.03 Million USD 100.0%
Avadel Pharmaceuticals plc 35.38 Million USD 100.0%
Shineco, Inc. 29.65 Million USD 100.0%
Talphera, Inc. - USD NaN%
Pacira BioSciences, Inc. 586.04 Million USD 100.0%
Aquestive Therapeutics, Inc. 98.82 Million USD 100.0%
Alvotech 1.07 Billion USD 100.0%
Hempacco Co., Inc. 13.72 Million USD 100.0%
Eagle Pharmaceuticals, Inc. 62.46 Million USD 100.0%
Lantheus Holdings, Inc. 616.94 Million USD 100.0%
Bright Green Corporation 1.85 Million USD 100.0%
Esperion Therapeutics, Inc. 540.94 Million USD 100.0%
Kamada Ltd. 8.74 Million USD 100.0%
Indivior PLC 281.6 Million USD 100.0%
Evoke Pharma, Inc. 5 Million USD 100.0%
Flora Growth Corp. 3.67 Million USD 100.0%
Cyclo Therapeutics, Inc. 1.03 Million USD 100.0%
Evolus, Inc. 126.54 Million USD 100.0%
HUTCHMED (China) Limited 86.13 Million USD 100.0%
Amphastar Pharmaceuticals, Inc. 623.64 Million USD 100.0%
Akanda Corp. 3.99 Million USD 100.0%